Furthermore, not only is the ratio between the CD39+ and the CD39− Treg higher in the tumor tissue compared to unaffected tissue, but the CD39+ Treg in the tumor also have a higher density of CD39 on the cell surface than CD39+ Treg in unaffected tissue (Figure 1D). This evidence concerns the gene ENTPD1 and neoplasm.